ブース番号5N-16
カテゴリーアウトソーシング

Genovior Biotech Corporation

小間番号:5N-16
カテゴリー:アウトソーシング
企業情報
Email: contact@genovior.com.tw TEL: 住所: 4F, 50-8, Keyan Road, Zhunan Township Taiwan 35053 35053 URL: http://
Genovior is a dedicated CDMO focus on process development, scale up, formulation development, and productivity optimization under PIC/S GMP (cGMP, EU GMP) for our customers worldwide. Our one-stop services conveniently provide effective and efficient solution and our non-competition policy provides maximum security and protection in IP for our clients.

Genovior Biotech Corp. is a vertically integrated contract development and manufacture company, providing following services:
(a) process development of peptide or protein biologics from microbial or human recombinant fermentation processes
(b) formulation development of biological injectables
(c) manufacturing capacities of biologics, lyophilized injectable, and prefilled syringe/cartridge for preclinical, clinical, and commercial uses

企業情報

住所 4F, 50-8, Keyan Road, Zhunan Township Taiwan 35053 35053
URL http://
Email contact@genovior.com.tw
出展品目 Contract Manufacturing (CDMO/CMO) API
Contract Manufacturing (CDMO/CMO) Injectables
Pemetrexed Injection; 100mg & 500mg (Swissmedic & TFDA approved)
Bortezomib Injection; 3.5mg (TFDA approved)
Doxorubicin Injection; 10mg (TFDA approved)
Docetaxel Injection; 20mg/mL (1mL/vial) (TFDA approved)
Fulvestrant Injection; 250mg (TFDA approved)
Gemcitabine Injection; 200mg (TFDA approved)
Azacitidine Injection; 100mg (TFDA approved)
Gemcitabine Injection; 200mg (TFDA approved)
Ganciclovir Injection; 500mg (TFDA approved)
Fulvestrant (API)
Octreotide (API)
Pemetrexed (API)
Teriparatide (API)
Azacitidine (API)
Bortezomib (API)
Semaglutide Injection (in development)新製品
Carfilzomib Injection (in development)新製品
Teriparatide Injection (in development)

出展製品・サービス

Contract Manufacturing (CDMO/CMO) APIContract Manufacturing (CDMO/CMO) InjectablesPemetrexed Injection; 100mg & 500mg (Swissmedic & TFDA approved)Bortezomib Injection; 3.5mg (TFDA approved)Doxorubicin Injection; 10mg (TFDA approved)Docetaxel Injection; 20mg/mL (1mL/vial) (TFDA approved)Fulvestrant Injection; 250mg (TFDA approved)Gemcitabine Injection; 200mg (TFDA approved)Azacitidine Injection; 100mg (TFDA approved)Gemcitabine Injection; 200mg (TFDA approved)Ganciclovir Injection; 500mg (TFDA approved)Fulvestrant (API)Octreotide (API)Pemetrexed (API)Teriparatide (API)Azacitidine (API)Bortezomib (API)Semaglutide Injection (in development)新製品Carfilzomib Injection (in development)新製品Teriparatide Injection (in development)